Aloperidolo en es it fr

Aloperidolo Brand names, Aloperidolo Analogs

Aloperidolo Brand Names Mixture

  • No information avaliable

Aloperidolo Chemical_Formula


Aloperidolo RX_link

Aloperidolo fda sheet

Aloperidolo FDA

Aloperidolo msds (material safety sheet)

Aloperidolo MSDS

Aloperidolo Synthesis Reference

P. A. J. Janssen, Belg. pat. 577,977 (1959), C.A. 54, 4630c (1960); idem, Brit. pat. 895,309 corresp to U.S. pat. 3,438,991 (1962, 1969 to Janssen).

Aloperidolo Molecular Weight

375.864 g/mol

Aloperidolo Melting Point

151.5 oC

Aloperidolo H2O Solubility

14 mg/L

Aloperidolo State


Aloperidolo LogP


Aloperidolo Dosage Forms

Injection; Oral solution; Tablet

Aloperidolo Indication

For the treatment of schizophrenic patients who require prolonged parenteral antipsychotic therapy also used in Tourette's syndrome and Severe hyperactivity.

Aloperidolo Pharmacology

Haloperidol is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Haloperidol has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Haloperidol has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.

Aloperidolo Absorption


Aloperidolo side effects and Toxicity

LD50=165 mg/kg (rats, oral)

Aloperidolo Patient Information


Aloperidolo Organisms Affected

Humans and other mammals